-+ 0.00%
-+ 0.00%
-+ 0.00%

ZEALAND PHARMA - 2026 FINANCIAL GUIDANCE FOR COLLABORATION REVENUE, OPERATING EXPENSES UNCHANGED, TO BE DKK 4.5 BLN AND DKK 2.7-3.3 BLN, RESPECTIVELY

Reuters·08/13/2026 05:00:01

Please log in to view news